Plasma cells: Finding new light at the end of B cell development

Nature Immunology

Volumn 2, Issue 12, 2001, Pages 1103-1108

  Calame, K L ^a  

^a Columbia Univ College of Physicians ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; B LYMPHOCYTE; CELL FATE; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DNA MICROARRAY; GENETIC ENGINEERING; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

ANIMALS; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; IMMUNOGLOBULINS; IMMUNOLOGIC MEMORY; MICE; MODELS, IMMUNOLOGICAL; PLASMA CELLS; RECEPTORS, CHEMOKINE; SPLEEN; TRANSCRIPTION FACTORS;

EID: 0035194463     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1201-1103     Document Type: Review

References (85)

1. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival
2. Transcriptional control of μ- and κ-gene expression in resting and bacterial lipopolysaccharide-activated normal B cells
3. Levels of polyadenylation factor CstF-64 control IgM heavy chain mRNA accumulation and other events associated with B cell differentiation
4. Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA
5. Lymphocytes express and lose syndecan at specific stages of differentiation
6. A coordinated change in chemokine responsiveness guides plasma cell movements
7. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
8. Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis
9. A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation
10. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells
11. Commitment of B lymphocytes to a plasma cell fate is associated with blimp-I expression in vivo
12. Pip, a novel IRF family member, is a lymphoid-specific, PU. 1-dependent transcriptional activator
13. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells
14. Plasma cell differentiation requires the transcription factor XBP-1
15. IgA production without μ or δ chain expression in developing B cells
16. Development and maturation of secondary lymphoid tissues
17. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals
18. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory"
19. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells
20. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria
21. Generation, expansion, migration and activation of mouse B1 cells
22. Antigen drives very low affinity B cells to become plasmacytes and enter germinal centers
23. Long-lived B cells are distinguished by elevated expression of A1
24. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death
25. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos. Btk, and CD21
26. Aiolos regulates B cell activation and maturation to effector state
27. Defective B cell development and function in Btk-deficient mice
28. Baff-R, a newly identified TNF receptor that specifically interacts with BAFF
29. Interaction of the TNF homologues BLyS and APRIL with the TNF receptor homologues BCMA and TACI
30. Mechanism of BLyS action in B cell immunity
31. Germinal center reaction
32. + tonsillar plaoma cells are rescued from apoptosis by bone marrow fibroblasts
33. Humoral immunity due to long-lived plasma cells
34. The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response
35. Generation of memory B cells and plasma cells in vitro
36. The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response
37. IL-10 interrupts memory B cell expansion in the germinal center by inducing differentiation into plasma cells
38. The distinct roles of T cell-derived cytokines and a novel follicular dendritic cell-signaling molecule 8d6 in germinal center-B cell differentiation
39. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis
40. Induction of cell cycle arrest and B cell terminal differentiation by CDK inhibitor p18(INK4c) and IL-6
41. Role of interleukin-6 in the pathogenesis of multiple myeloma
42. Dendritic cells associated with plasmablast survival
43. B cell memory and the long-lived plasma cell
44. Memory B-cell persistence is independent of persisting immunizing antigen
45. Development and maintenance of a B220-memory B cell compartment
46. Memory B cells are biased towards terminal differentiation: A strategy that may prevent repertoire freezing
47. The differentiation of human memory B cells into specific antibody-secreting cells is CD40 independent
48. A new member of the leucine zipper class of proteins that binds to the HLA DR α promoter
49. An essential role in liver development for transcription factor XBP-1
50. Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1
51. Dependence of BSAP repressor and activator functions on BSAP concentration
52. Identification of c-myc promoter-binding protein and X-box binding protein I as interleukin-6 target genes in human multiple myeloma cells
53. ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response
54. Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-μ F(ab′)2-co-stimulated B lymphocytes
55. BLIMP-1 mediates extinction of major histocompatibility class II transactivator expression in plasma cells
56. Only two of the five zinc fingers of the eukaryotic transcriptional repressor PRDI-BF1 are required for sequence-specific DNA binding
57. PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins
58. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone
59. Suppression of signal transducer and activator of transcription 3-dependent B lymphocyte terminal differentiation by BCL-6
60. BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control
61. Arrest of B lymphocyte terminal differentiation by CD40 signaling: Mechanism for lack of antibody-secreting cells in germinal centers
62. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation
63. Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient to suppress differentiation to an Ig high producer cell with plasma cell phenotype
64. An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene
65. NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3′ α enhancer at early stages of B-cell differentiation
66. Lessons from the bare lymphocyte syndrome: Molecular mechanisms regulating MHC class II expression
67. Repression of c-myc is necessary but not sufficient for terminal differentiation of B lymphocytes in vitro
68. Pax5/bsap maintains the identity of B cells in late b lymphopoiesis
69. Control of inflammation, cytokine expression, and germinal center formation by BCL-6
70. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
71. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme
72. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function
73. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE)
74. Interferon regulatory factors: The next generation
75. Lineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4
76. Stage-specific modulation of IFN-regulatory factor 4 function by kruppel-type zinc finger proteins
77. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes. Modulation of interferon-regulated gene expression by rel/nuclear factor κB
78. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU. I
79. Transcription factors of the NFAT family: Regulation and function
80. NFATcI and NFATc2 together control both T and B cell activation and differentiation
81. Lymphoid-specific transcription mediated by the conserved octamer site: Who is doing what?
82. Oct-2 is required early in T cell-independent B cell activation for GI progression and for proliferation
83. OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development
84. B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-I
85. Antigen receptor signaling induces MAP kinase-mediated phosphorylation and degradation of the BCL-6 transcription factor